Stock ALGS ALIGOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aligos Therapeutics, Inc.

Equities

ALGS

US01626L1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
0.58 USD -3.33% Intraday chart for Aligos Therapeutics, Inc. -15.76% -12.65%
Apr. 03 Aligos Therapeutics, Inc. Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects CI
Mar. 27 Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALIGOS THERAPEUTICS, INC. Stock Aligos Therapeutics, Inc.
 45.3M - - - -
MODERNA, INC. Stock Moderna, Inc.
 63.85B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.83B
LONZA GROUP AG Stock Lonza Group AG
 40.65B
CELLTRION, INC. Stock Celltrion, Inc.
 27.12B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.52B
  1. Stock Market
  2. Equities
  3. ALGS Stock
  4. Charts Aligos Therapeutics, Inc.
  5. Sector Chart